ACW 4.00% 4.8¢ actinogen medical limited

2014 trial of similar drug

  1. 394 Posts.
    lightbulb Created with Sketch. 3
    I presume investors here are aware of this trial:

    Alzheimers Dement. 2014 Oct;10(5 Suppl):S364-73. doi: 10.1016/j.jalz.2013.09.010. Epub 2014 Jan 10.
    Efficacy and safety evaluation of HSD-1 inhibitor ABT-384 in Alzheimer's disease.
    Marek GJ1, Katz DA2, Meier A2, Greco N 4th2, Zhang W2, Liu W2, Lenz RA2.
    Author information
    Abstract
    BACKGROUND:
    In this study we assessed increased cortisol in Alzheimer's disease (AD) patients. The selective 11-β-hydroxysteroid dehydrogenase type 1 (HSD-1) inhibitor ABT-384 blocked regeneration of active cortisol and this tests the hypothesis that intracellular hypercortisolism contributes to cognitive impairment.
    METHODS:
    In this double-blind, placebo- and active-controlled phase II study we examine the efficacy and safety of ABT-384 given 10 mg or 50 mg once daily, donepezil 10 mg once daily, or placebo for 12 weeks in subjects with mild-to-moderate AD. The primary efficacy end point was the change from baseline to final evaluation on the 13-item Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) total score.
    RESULTS:
    The study was terminated for futility after randomization of 267 subjects. ABT-384 did not improve ADAS-Cog scores or any secondary end point; however, donepezil significantly improved both cognition and functional end points. Overall incidence of adverse events was similar among treatment groups.
    CONCLUSION:
    ABT-384, when tested at doses associated with complete brain HSD-1 inhibition, did not produce symptomatic improvement in AD.
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
4.8¢
Change
-0.00(4.00%)
Mkt cap $53.66M
Open High Low Value Volume
4.9¢ 4.9¢ 4.7¢ $39.63K 836.4K

Buyers (Bids)

No. Vol. Price($)
1 1142 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 91305 1
Last update - 16.10pm 11/12/2018 (20 minute delay) ?
(live)
Last
4.8¢
  Change
-0.00 ( 4.00 %)
Open High   Low Volume
4.8¢ 4.8¢   4.6¢ 209797
Last updated 15.59pm 11/12/2018 (live) ?
ACW (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.